Modified Instrumentation for Surgery to Correct Trichiasis
Partnership for the Rapid Elimination of Trachoma (PRET) Clinical Trial of Evaluation of Modified Instrumentation for Surgery to Correct Trichiasis
1 other identifier
interventional
1,927
1 country
1
Brief Summary
Trachoma, an ocular infection caused by C. trachomatis, is the second leading infectious cause of blindness worldwide. Years of repeated infection with C. trachomatis cause the eyelid to scar and contract and ultimately to rotate inward such that the eyelashes rub against the eyeball and abrade the cornea (trichiasis). The World Health Organization (WHO) has endorsed a multi-faceted strategy to combat trachoma which includes surgery to repair lids distorted by trachoma (trichiasis) in imminent danger of vision loss. Current evidence suggests that long-term success rates of trichiasis surgery are less than optimal due to variation in surgical technique. Previous research by this study team has demonstrated that shorter incisions have a higher rate of trichiasis recurrence. In addition, observations by this team's oculoplastic surgeon have led to the hypothesis that granuloma formation and lid contour abnormalities may result from current surgical practices. The objective of this study is to compare outcomes of trichiasis surgeries performed with the newly developed trachomatous trichiasis (TT) clamp versus surgeries following standard technique (bilamellar tarsal rotation procedure or BLTR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2009
CompletedFirst Posted
Study publicly available on registry
April 22, 2009
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedResults Posted
Study results publicly available
May 19, 2017
CompletedMay 19, 2017
April 1, 2017
2.7 years
April 21, 2009
August 3, 2016
April 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of Eyelids With Presence of Recurrent Trichiasis
Trichiasis: 1 or more eyelashes touching globe in primary position
2 years
Number of Eyelids With Pyogenic Granuloma
A pyogenic granuloma was defined as a sessile growth of 2 mm or more in diameter on the tarsal conjunctiva.
2 years
Number of Eyelids Experiencing an Unfavorable Outcome
At least 1 unfavorable outcome, including mild, moderate, or severe trichiasis; granuloma; or mild, moderate, or severe eyelid contour abnormality
2 years
Number of Eyelids With Normal or Mild Eyelid Contour Abnormalities vs Moderate or Severe Eyelid Contour Abnormalities
Eyelid contour abnormalities (ECA) were graded by photographs of the eyes. In the primary outcome measure, normal eyes and mild eyelid contour abnormalities are considered together, and moderate or severe eyelid contour abnormalities are considered together. ECA severity is defined as follows: Mild: Vertical deviation from the natural contour \< 1 mm in height (less than half the pupil height in daylight) and affecting \< 1/3 of horizontal eyelid length; Moderate: Vertical deviation from the natural contour 1-2 mm in height (about the pupil height in daylight) or affecting 1/3-2/3 of horizontal eyelid length; Severe: Vertical deviation from the natural contour \> 2 mm in height (more than the pupil height in daylight) or a defect \> 2/3 of the horizontal eyelid length
2 years
Secondary Outcomes (2)
Number of Eyelids With Mild, Moderate, Severe, or no Eyelid Contour Abnormality
2 years
Number of Eyelids With Normal, Mild, Moderate, or Severe Trachomatous Trichiasis
2 Years
Study Arms (2)
TT Clamp
EXPERIMENTALThe TT clamp will be used in trichiasis surgery.
Standard BLTR Technique
ACTIVE COMPARATORStandard BLTR technique will be used in trichiasis surgery.
Interventions
bilamellar tarsal rotation procedure in trichiasis surgery
Eligibility Criteria
You may qualify if:
- Presence of upper lid trichiasis: defined by at least one eyelash touching the globe of the eye or evidence of epilation
- No previous report of trichiasis surgery in at least one eye with trichiasis:
- if unilateral surgery has been performed previously, only the eye without prior history of surgery will be in the study, even if both eyes require surgery
- Age 18 or older (in order to provide consent as an adult): the vast majority of trichiasis patients are aged 18 or older
- At time of enrollment, subjects must state their intention to remain in the area for two years to facilitate study follow-up
You may not qualify if:
- Absence of upper lid trichiasis
- Prior trichiasis surgery on both eyes
- Age 18 or younger
- Subjects who are transiently in the area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- Bill and Melinda Gates Foundationcollaborator
Study Sites (1)
Johns Hopkins University
Baltimore, Maryland, 21205, United States
Related Publications (2)
Gower EW, Munoz B, Rajak S, Habtamu E, West SK, Merbs SL, Harding JC, Alemayehu W, Callahan EK, Emerson PM, Gebre T, Burton MJ. Pre-operative trichiatic eyelash pattern predicts post-operative trachomatous trichiasis. PLoS Negl Trop Dis. 2019 Oct 7;13(10):e0007637. doi: 10.1371/journal.pntd.0007637. eCollection 2019 Oct.
PMID: 31589610DERIVEDGower EW, West SK, Harding JC, Cassard SD, Munoz BE, Othman MS, Kello AB, Merbs SL. Trachomatous trichiasis clamp vs standard bilamellar tarsal rotation instrumentation for trichiasis surgery: results of a randomized clinical trial. JAMA Ophthalmol. 2013 Mar;131(3):294-301. doi: 10.1001/jamaophthalmol.2013.910.
PMID: 23494035DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sheila West
- Organization
- JohnHopkins U
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Gower, PhD
Johns Hopkins University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Ophthalmology
Study Record Dates
First Submitted
April 21, 2009
First Posted
April 22, 2009
Study Start
May 1, 2009
Primary Completion
January 1, 2012
Study Completion
June 1, 2012
Last Updated
May 19, 2017
Results First Posted
May 19, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will share
Deidentified data will be provided to investigators through application to the data committee at Johns Hopkins University.